Shopping Cart 0
Cart Subtotal
AED 0

Sequenom Inc (SQNM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 0

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 0

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 0

Details

Summary

Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby's whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.

Sequenom Inc (SQNM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sequenom Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Sequenom Inc, Medical Devices Deals, 2011 to YTD 2017 9

Sequenom Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sequenom Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 11

Partnerships 11

Sequenom enters into an Agreement with University of California 11

Sequenom Enters into Agreement with University of Colorado Denver 12

Sequenom Enters into Agreement with University Medical Center Hamburg 13

Sequenom Enters into Agreement with Seoul National University Hospital 13

Licensing Agreements 14

New England Biolabs Enters Into Licensing Agreement With Sequenom 14

Equity Offering 15

Sequenom Completes Public Offering Of Common Stock For US$62 Million 15

Debt Offering 17

Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 17

Acquisition 18

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 18

Sequenom Inc-Key Competitors 20

Key Employees 21

Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Financial Announcements 24

May 04, 2016: Sequenom Reports First Quarter 2016 Results 24

Mar 02, 2016: Sequenom Reports 2015 Financial Results 26

Legal and Regulatory 28

Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent 28

Other Significant Developments 29

Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Sequenom Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sequenom Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Sequenom Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Sequenom Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sequenom Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sequenom Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Sequenom Inc, Medical Devices Deals, 2011 to YTD 2017 9

Sequenom Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 11

Sequenom enters into an Agreement with University of California 11

Sequenom Enters into Agreement with University of Colorado Denver 12

Sequenom Enters into Agreement with University Medical Center Hamburg 13

Sequenom Enters into Agreement with Seoul National University Hospital 13

New England Biolabs Enters Into Licensing Agreement With Sequenom 14

Sequenom Completes Public Offering Of Common Stock For US$62 Million 15

Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 17

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 18

Sequenom Inc, Key Competitors 20

Sequenom Inc, Key Employees 21

Sequenom Inc, Other Locations 22

Sequenom Inc, Subsidiaries 22

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Sequenom Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Sequenom Inc (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby's whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.

Sequenom Inc (SQNM)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sequenom Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Sequenom Inc, Medical Devices Deals, 2011 to YTD 2017 9

Sequenom Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sequenom Inc, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 11

Partnerships 11

Sequenom enters into an Agreement with University of California 11

Sequenom Enters into Agreement with University of Colorado Denver 12

Sequenom Enters into Agreement with University Medical Center Hamburg 13

Sequenom Enters into Agreement with Seoul National University Hospital 13

Licensing Agreements 14

New England Biolabs Enters Into Licensing Agreement With Sequenom 14

Equity Offering 15

Sequenom Completes Public Offering Of Common Stock For US$62 Million 15

Debt Offering 17

Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 17

Acquisition 18

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 18

Sequenom Inc-Key Competitors 20

Key Employees 21

Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 24

Financial Announcements 24

May 04, 2016: Sequenom Reports First Quarter 2016 Results 24

Mar 02, 2016: Sequenom Reports 2015 Financial Results 26

Legal and Regulatory 28

Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent 28

Other Significant Developments 29

Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Sequenom Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sequenom Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Sequenom Inc, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Sequenom Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Sequenom Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Sequenom Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Sequenom Inc, Deals By Therapy Area, 2011 to YTD 2017 8

Sequenom Inc, Medical Devices Deals, 2011 to YTD 2017 9

Sequenom Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million 11

Sequenom enters into an Agreement with University of California 11

Sequenom Enters into Agreement with University of Colorado Denver 12

Sequenom Enters into Agreement with University Medical Center Hamburg 13

Sequenom Enters into Agreement with Seoul National University Hospital 13

New England Biolabs Enters Into Licensing Agreement With Sequenom 14

Sequenom Completes Public Offering Of Common Stock For US$62 Million 15

Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million 17

Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million 18

Sequenom Inc, Key Competitors 20

Sequenom Inc, Key Employees 21

Sequenom Inc, Other Locations 22

Sequenom Inc, Subsidiaries 22

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Sequenom Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.